Skip to main content
OpenTrials

Clinical trial condition

SARS-CoV-2

Explore clinical trials studying SARS-CoV-2. Study availability and eligibility vary by location and protocol.

173 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

SARS-CoV-2 trial results

Completed

Study of Self-Amplifying Messenger Ribonucleic Acid (samRNA) Vaccines Against COVID-19 in Healthy Adults and People Living With Human Immunodeficiency Virus (HIV)

NCT05435027

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, COVID-19, +23 more
Locations
  • Newtown Clinical Research Centre Johannesburg, South Africa
  • WITS RHI Shandukani Research Centre Johannesburg, South Africa
  • Wits Vaccines & Infections Diseases Analytics (VIDA) Research Unit Johannesburg, South Africa
  • Setshaba Research Center Pretoria, South Africa
View Trial Details
Completed

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old

NCT05585632

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +14 more
Locations
  • Accel Research Sites DeLand, Florida, United States
  • Research Centers of America (cenexel) Hollywood, Florida, United States
  • Accel Research Sites St. Petersburg, Florida, United States
  • Atlanta Center for Medical Research - Family Medicine Atlanta, Georgia, United States
View all 30 locations
View Trial Details
Completed

NOWDx Test for the Detection of Antibodies to COVID-19

NCT04690413

Conditions
COVID-19, Coronaviridae Infections, Coronavirus, +11 more
Locations
  • Del Sol Research Management, LLC Tucson, Arizona, United States
  • Comprehensive Clinical Research, LLC West Palm Beach, Florida, United States
  • Clinical Research Solutions, LLC Jackson, Tennessee, United States
View Trial Details
Completed

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1073 (COVID-19/Influenza) Vaccine in Adults 18 to 75 Years Old

NCT05375838

Conditions
Infections, Influenza, Influenza, Human, +6 more
Locations
  • Research Centers of America Hollywood, Florida, United States
  • AES - DRS - Optimal Research Illinois - Peoria Peoria, Illinois, United States
  • Meridian Sioux City, Iowa, United States
  • Benchmark Research Metairie, Louisiana, United States
View all 14 locations
View Trial Details
Completed

A Clinical Trial of a Prophylactic Plasmid DNA Vaccine for COVID-19 [Covigenix VAX-001] in Adults

NCT04591184

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • National Center for Research and Training on Malaria Ouagadougou, Burkina Faso
  • Canadian Centre for Vaccinology, Dalhousie University Halifax, Nova Scotia, Canada
  • Institute for Health Research, Epidemiological Surveillance and Training (IRESSEF) Dakar, Senegal
  • FARMOVS (PTY) Ltd. Bloemfontein, South Africa
View Trial Details
Completed

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

NCT04516746

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Research Site Phoenix, Arizona, United States
  • Research Site Scottsdale, Arizona, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Berkeley, California, United States
View all 84 locations
View Trial Details

Related conditions